Optometry Medications Supply Early Adopter West Dunbartonshire & - - PowerPoint PPT Presentation

Optometry Medications Supply

Early Adopter West Dunbartonshire & Inverclyde CHCPs

The Concept

• Optometrists will supply from a range of

medications as deemed appropriate to the patient’s presenting signs and symptoms.

• Optometrists are now the ‘First Port of Call’

for all eye conditions in the community

• Can we devise a method to allow

Optometrists to supply these medications, to NHS standards, direct to patients at the point

• f diagnosis?

The Hurdles

• The Cost difference – Optometry cannot

source eye preparations at the NHS Tariff price.

• Easy access to the preparations by Optometry

Practices

• Correct labelling of the product.
• Understanding the Cost Implications of

creating hundreds of new prescribers.

The Key Elements

• Agreement from other professional groups that

this should improve the service.

• Medications and Healthcare products Regulatory

Authority(MHRA) advise that Optometrists can label eye products.

• Agreement that Optometry practices can source

the listed products at the agreed tariff price.

• Agreed GGC forms to record the supply & claim

payments.

• Pilot the roll out to assess the service and cost

implications.

The Solutions

• Optometrists buy from current supplier and keep

stock appropriate to their own needs

• Optometrists label product within their own

practice (legal requirement).

• Patients sign a form indicating they have received

the stated preparations

• GGC process claims and PSD pay the submissions

within the monthly schedule.

• Prescribing Support & PCS monitor activity and

costs

The Medication List

• Hypromellose 0.3%
• Carbomer gel 980
• Lacrilube Eye Ointment
• Chloramphenicol 0.5% Eye drops
• Chloramphenicol 1% Eye ointment
• Fucidic acid 1% viscous Eye drops
• Sodium Cromoglicate 2% Eye drops
• Olopatidine 1mg/ml (requires PGD)

Additional PGD

• The Patient Group Direction (PGD) allows

Optometrists to supply a Prescription Only Medicine under defined circumstances.

• Pharmacy and Optometry combine to create a

PGD for Olopatadine 1mg/ml

• Approval gained.
• Optometrists decide whether to sign up to be

able to supply Olopatadine according to the terms of the PGD.

Labelling

• The name of the patient
• The name of the medicine
• Directions for use
• BNF precautions relating to the use of the medicine
• The words “Keep out of the reach and sight of

children”

• The words “For external use only”
• Date of dispensing
• Name and address of the optometric practice

Label Example

Wilkie & Rider, 3 College Way, Dumbarton Keep out of the reach and sight of children FOR EXTERNAL USE ONLY 5ml Opatanol 0.1% EYE DROPS Put One drop(s) into the _____ eye(s) TWICE daily. Discard contents FOUR WEEKS after opening. Patient:______________Date:_______

Glasgow Formulary

• DRY EYE
• Hypromellose 0.3% is considered the first line

treatment option for patients complaining of ‘dry eyes’ or tear deficiency.

• CARBOMER 980 (CLINITAS GEL) (EYE DROPS)
• carbomer 980 (VISCOTEARS)
• carbomer 980 (GELTEARS)
• LIQUID PARAFFIN (LACRI‐LUBE) (Eye ointme

Glasgow Formulary Anti Infective

• CHLORAMPHENICOL Prescribing Notes:
• Available as 0.5% drops (which must be stored

in a fridge), and 1% eye ointment.

• FUSIDIC ACID Prescribing Notes: Available as

modified‐release 1% viscous eye drops. Fusidic acid should only be used for staphylococcal infections such as blepharitis, not bacterial conjunctivitis.

Glasgow Formulary‐ Anti Inflammatory

• SODIUM CROMOGLICATE (2%) (EYE

DROPS)Prescribing Notes: The 2% eye drops are the first‐line anti‐inflammatory preparation.

• OLOPATADINE (EYE DROPS)Restrictions:

Restricted to second‐line when sodium cromoglicate is ineffective or not tolerated.

• www.ggcprescribing.org.uk

The College of Optometrists Guidelines

• Tear deficiency
• Blepharitis
• Conjunctivitis‐ acute allergic
• Conjunctivitis ‐ bacterial

www.college‐optometrists.org Members log in – clinical management guidelines

Payment Verification

• Separate record card per NHS investigation –

primary or supplementary.

• Medication supplied written on card.
• Patient Medication Supply form completed,

signed and retained in monthly batch.

• Summary form completed and sent every

month, duplicate retained.

Governance

• The GOS aspect of the Early Adopter/Pilot is

no different from any other examination.

Extra Information required

• Medication – Type, batch no and expiry date.
• Patient Instructions – Frequency and duration of

treatment.

• Follow up – further appointment, contact details,

and reporting procedure.

• Copy of GP Communication form.

Governance

• Monitoring of Rx Supply will be carried out by

Margaret Ryan, (Lead of Prescribing Governance for NHSGG&C) and her team. They will receive regular reports on the supply activity from PCS/PSD

Questions